Literature DB >> 17559883

Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care.

Michael T Froehler1, Romergryko G Geocadin.   

Abstract

Therapeutic hypothermia is a proven part of cardio-cerebral resuscitation after cardiac arrest as it improves neurologic outcomes after hypoxic brain injury. This article reviews the mechanisms of hypothermic neuroprotection, the clinical trials that support its use after cardiac arrest, as well as the impact of hypothermia on patient management and prognosis. In caring for patients suffering hypoxic brain injury after cardiac arrest, the role of the neurologist is no longer limited to prognosis but is now to become actively involved in clinical management which includes the use of therapeutic hypothermia.

Entities:  

Mesh:

Year:  2007        PMID: 17559883     DOI: 10.1016/j.jns.2007.04.042

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Feasibility of intra-arrest hypothermia induction: A novel nasopharyngeal approach achieves preferential brain cooling.

Authors:  Manuel Boller; Joshua W Lampe; Joseph M Katz; Denise Barbut; Lance B Becker
Journal:  Resuscitation       Date:  2010-06-09       Impact factor: 5.262

Review 2.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 3.  Modern approaches to pediatric brain injury therapy.

Authors:  Peter A Walker; Matthew T Harting; James E Baumgartner; Stephen Fletcher; Nathan Strobel; Charles S Cox
Journal:  J Trauma       Date:  2009-08

4.  Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical Trial.

Authors:  Per Nordberg; Fabio Silvio Taccone; Anatolij Truhlar; Sune Forsberg; Jacob Hollenberg; Martin Jonsson; Jerome Cuny; Patrick Goldstein; Nick Vermeersch; Adeline Higuet; Francisco Carmona Jiménes; Fernando Rosell Ortiz; Julia Williams; Didier Desruelles; Jacques Creteur; Emelie Dillenbeck; Caroline Busche; Hans-Jörg Busch; Mattias Ringh; David Konrad; Johan Peterson; Jean-Louis Vincent; Leif Svensson
Journal:  JAMA       Date:  2019-05-07       Impact factor: 56.272

5.  Therapeutic hypothermia after cardiac arrest: experience at an academically affiliated community-based veterans affairs medical center.

Authors:  Maulik P Shah; Leslie Zimmerman; Jean Bullard; Midori A Yenari
Journal:  Stroke Res Treat       Date:  2011-07-12

Review 6.  Targeted temperature management in neurological intensive care unit.

Authors:  Sombat Muengtaweepongsa; Winchana Srivilaithon
Journal:  World J Methodol       Date:  2017-06-26

Review 7.  SSEP retains its value as predictor of poor outcome following cardiac arrest in the era of therapeutic hypothermia.

Authors:  Ted L Rothstein
Journal:  Crit Care       Date:  2019-10-23       Impact factor: 9.097

8.  Prehospital therapeutic hypothermia in cardiac arrest: will there ever be evidence?

Authors:  Joerg C Schefold; Christian Storm; Dietrich Hasper
Journal:  Crit Care       Date:  2008-04-09       Impact factor: 9.097

9.  Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls.

Authors:  Christian Storm; Ingo Steffen; Joerg C Schefold; Anne Krueger; Michael Oppert; Achim Jörres; Dietrich Hasper
Journal:  Crit Care       Date:  2008-06-14       Impact factor: 9.097

10.  Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial.

Authors:  Akil Awad; Fabio Silvio Taccone; Martin Jonsson; Sune Forsberg; Jacob Hollenberg; Anatolij Truhlar; Mattias Ringh; Benjamin S Abella; Lance B Becker; Jean-Louis Vincent; Leif Svensson; Per Nordberg
Journal:  Intensive Care Med       Date:  2020-06-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.